Emergent Biosolutions INC DEF 14A proxy statements

Emergent BioSolutions announces its 2026 annual meeting of stockholders, detailing director elections, auditor ratification, executive compensation, and a critical proposal to increase shares for its stock incentive plan.

Emergent BioSolutions Inc. is holding its 2025 Annual Meeting on April 30, 2025, and stockholders are encouraged to vote on key proposals.

Emergent BioSolutions' 2025 proxy statement highlights the company's efforts to stabilize its financials, turnaround the business, and transform for sustainable stockholder value, while detailing executive compensation and corporate governance practices.

Emergent BioSolutions Inc. will hold its annual stockholder meeting on May 23, 2024, to vote on key proposals including the election of directors, ratification of the company's accounting firm, executive compensation, and an amendment to the stock incentive plan.

Emergent BioSolutions will hold its 2024 annual meeting of stockholders virtually on May 23, 2024, to vote on director elections, ratification of the accounting firm, executive compensation, and an amendment to the stock incentive plan.